Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 174,350	$ 202,004
Marketable securities available-for-sale	477,606	422,391
Accounts receivaAccounts receivables, net of allowance for doubtful accounts of $12,313 and $0 at March 31, 2023 and December 31, 2022, respectivelybles, net	101,738	145,130
Other receivables	3,128	2,385
Inventories, net	57,693	59,446
Prepaid expenses and other current assets	15,626	85,629
Total current assets	830,141	916,985
Property and equipment, net	38,159	37,596
Operating lease right-of-use assets	25,433	25,745
Goodwill	2,038	2,006
Restricted cash	210	207
Other assets	73,941	3,311
Total assets	969,922	985,850
Current liabilities:
Accounts payable	7,296	3,211
Accrued research and development	5,155	4,775
CEPI accrual (Note 6)	47,401	107,738
Accrued liabilities	27,833	30,719
Other current liabilities	3,830	3,631
current liabilities	91,515	150,074
Convertible Notes, net of debt discount of $3,645 and $3,922 at March 31, 2023 and December 31, 2022, respectively (Note 7)	221,855	221,578
Long-term portion of lease liabilities	32,131	32,801
CEPI accrual long-term	60,337	0
Other long-term liabilities	352	384
Total liabilities	406,190	404,837
Commitments and contingencies (Note 5)
Stockholders’ equity:
Common stock: $0.001 par value; 278,000 shares authorized at March 31, 2023 and December 31, 2022; 128,472 shares and 127,604 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	128	128
Preferred stock: $0.001 par value; 5,000 shares authorized at March 31, 2023 and December 31, 2022; zero shares outstanding at March 31, 2023 and December 31, 2022, respectively	0	0
Additional paid-in capital	1,516,331	1,510,518
Accumulated other comprehensive (loss) gain	(4,200)	(5,438)
Accumulated deficit	(948,527)	(924,195)
Total stockholders’ equity	563,732	581,013
Total liabilities and stockholders’ equity	$ 969,922	$ 985,850